642
Participants
Start Date
December 31, 2007
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
MCI-196
3g to 15g/day (3 times a day), Tablet, 12 weeks of fixed dose of study
Placebo
3g to 15g/day (3 times a day), Tablet, 12 weeks of fixed dose of study
Ajka
Baja
Budapest
Esztergom
Győr
Hatvan
Kisvárda
Lecco
Modena
Pavia
Roma
Alor Star
Ipoh
Kajang
Klang
Kota Kinabalu
Kuala Terengganu
Kuantan
Kuching
Malacca
Seremban
Taiping
Skopje
Lodz
Poznan
Płock
Rybnik
Warsaw
Wroclaw
Zielona Góra
Arkhangelsk
Armavir
Chelyabinsk
Chita
Irkutsk
Ivanovo
Kaluga
Kemerovo
Khabarovsk
Krasnodar
Krasnoyarsk
Moscow
Nizhny Novgorod
Novokuznetsk
Novorossiysk
Novosibirsk
Omsk
Petrozavodsk
Rostov-on-Don
Saint Petersburg
Smolensk
Tomsk
Tver'
Tyumen
Vladimir
Vladivostok
Volzhskiy
Yaroslavl
Yekaterinburg
Belgrade
Kragujevac
Niš
Novi Sad
Chernivtsi
Dnipro
Ivano-Frankivsk
Kharkiv
Kiev
Mykolaiv
Ternopil
Uzhhorod
Zaporizhya
Zhytomyr
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
INDUSTRY